David Mott - Jun 10, 2023 Form 4 Insider Report for NOVAVAX INC (NVAX)

Role: Director
Signature: /s/ John A. Herrmann III, Attorney-in-Fact
Stock symbol: NVAX
Transactions as of: Jun 10, 2023
Transactions value $: $0
Form type: 4
Date filed: 6/13/2023, 04:47 PM
Previous filing: Jun 12, 2023
Next filing: Jun 16, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVAX	Common Stock	Options Exercise		+3.1K	+7.62%		43.8K	Jun 10, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NVAX	Restricted Stock Units	Options Exercise	$0	-3.1K	-100%	$0.00^*	0	Jun 10, 2023	Common Stock	3.1K		Direct	F1, F2
transaction	NVAX	Stock Option (Right to Buy)	Award	$0	+7.71K		$0.00	7.71K	Jun 12, 2023	Common Stock	7.71K	$7.78	Direct	F3
transaction	NVAX	Restricted Stock Units	Award	$0	+6.67K		$0.00	6.67K	Jun 12, 2023	Common Stock	6.67K		Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
F2	One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), vested on the first anniversary of the June 10, 2022 grant date subject to continued service on the Company's Board of Directors through the vesting date.
F3	One hundred percent (100%) of the shares subject to this option grant under the Plan will vest one (1) year from the June 12, 2023 grant date (the "Grant Date") subject to continued service on the Company's Board of Directors through the vesting date.
F4	One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date.